FIELD: medicine, pharmacology. SUBSTANCE: the suggested "SOBI" gel contains silver sulfadiazine, dimethylsulfoxide and alcoholic propolis tincture, and polyethylenoxide gel PEG- 1500 as a foundation at the following ratio of components per 100 ml: silver sulfadiazine 1-1.5 g; dimethylsulfoxide 10-15 ml; 10%-alcoholic propolis tincture prepared on 80%-alcohol 10-15 ml, polyethylenoxide gel PEG-1500 - the rest, moreover, the size of silver sulfadiazine particles does not exceed 5-10 mcm. EFFECT: higher efficiency of therapy. 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL COMPOSITION FOR TREATMENT OF HIV-INFECTED PATIENTS WITH HIGH VIRAL LOADING | 2001 |
|
RU2209072C2 |
| ANTIVIRAL COMPOSITION, METHOD OF ITS ACTIVE COMPONENT PREPARING AND METHOD OF TREATMENT OF HIV-INFECTED PATIENTS WITH SAID COMPOSITION | 2001 |
|
RU2192870C1 |
| OINTMENT FOR TREATMENT OF INFECTED WOUNDS | 1996 |
|
RU2146127C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| GEL-BASE FOR WOUND HEALING AND COSMETIC PREPARATION AND METHOD OF ITS OBTAINING | 2011 |
|
RU2485938C1 |
| COMPOSITION SHOWING ANTI-HIV AND ANTI-HERPES ACTIVITY | 2001 |
|
RU2182828C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| CELLULAR SUSPENSION-BASE DRUG AND METHOD OF TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV-INFECTION) USING THIS PREPARATION | 1994 |
|
RU2137484C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
